跳至主要内容
临床试验/NL-OMON41127
NL-OMON41127已完成不适用

A randomized, cross-over, dose-response trial of tyrosine and its effect on working memory in healthy elderly and young people - FOCOM DoReTy study

Wageningen Universiteit0 个研究点目标入组 34 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Aged 18-35 years or aged 60-75 years
  • Normal and stable weight (BMI 18.5-25 kg/m2 and weight 50-95 kg)
  • Willing to abstain from blood donation during the study
  • Dutch-speaking
  • Non-smoking
  • Normal or corrected-to-normal vision

排除标准

  • Thyroid problems, such as hyperthyroidism, hypothyroidism, thyroid cancer
  • Using medication that can interfere with tyrosine*s action; monoamine oxidase inhibitors and other antidepressants, sympathomimetic amines, and opioids
  • Following a low-protein diet as prescribed by a dietician or physician
  • Parkinson*s Disease
  • Depression
  • Use of tyrosine supplements
  • Being allergic or having a dislike to the product carrier (banana-flavored yoghurt)
  • Bad venous access, as judged by the research nurse
  • Mini Mental State Examination (MMSE) score < 24 (to exclude cognitive impaired participants, only for elderly participants)
  • Estimated IQ < 85 (based on Nederlandse Leestest voor Volwassenen (NLV) -score)
  • (History of) clinically significant psychiatric disorder
  • (History of) clinically significant neurological disorder, such as brain infarct, chronic migraine, major depression
  • Under treatment for cardiac or vascular diseases and use of medication for these conditions
  • General medical conditions, such as repetitive strain injury (RSI) or sensori-motor handicaps, as judged by the investigator
  • Alcohol consumption of more than 14 (women) or 21 (men) units per week

研究者

相似试验